Showing results (21-30 of 108) with videos related to
Sort By:
Pageof 11
Cancer Research|August 23, 2013
EGFR-activating mutations correlate with a Fanconi anemia-like cellular phenotype that includes PARP inhibitor sensitivityHeike N Pfäffle, Meng Wang, Liliana Gheorghiu, et al.Cancer Research|July 21, 2018
Oligosaccharyltransferase Inhibition Overcomes Therapeutic Resistance to EGFR Tyrosine Kinase InhibitorsCecilia Lopez Sambrooks, Marta Baro, Amanda Quijano, et al.Cancer Discovery|January 8, 2015
A coding single-nucleotide polymorphism in lysine demethylase KDM4A associates with increased sensitivity to mTOR inhibitorsCapucine Van Rechem, Joshua C Black, Patricia Greninger, et al.Clinical Chemistry|December 8, 2019
Simultaneous Detection of Gene Fusions and Base Mutations in Cancer Tissue Biopsies by Sequencing Dual Nucleic Acid Templates in Unified ReactionZhengbo Song, Chunwei Xu, Yunwei He, et al.Cancer Research|August 24, 2018
A Novel Microtubule Inhibitor Overcomes Multidrug Resistance in TumorsNannan Ning, Yamei Yu, Min Wu, et al.Proceedings of the National Academy of Sciences of the United States of America|December 12, 2013
PI3K regulates MEK/ERK signaling in breast cancer via the Rac-GEF, P-Rex1Hiromichi Ebi, Carlotta Costa, Anthony C Faber, et al.Nature Communications|July 5, 2020
Predicting and affecting response to cancer therapy based on pathway-level biomarkersRotem Ben-Hamo, Adi Jacob Berger, Nancy Gavert, et al.Cancer Research|March 21, 2014
EGFR-mediated chromatin condensation protects KRAS-mutant cancer cells against ionizing radiationMeng Wang, Ashley M Kern, Marieke Hülskötter, et al.Plos One|October 28, 2015
Combinations of PARP Inhibitors with Temozolomide Drive PARP1 Trapping and Apoptosis in Ewing's SarcomaSonja J Gill, Jon Travers, Irina Pshenichnaya, et al.Plos Biology|August 30, 2018
BRAF and AXL oncogenes drive RIPK3 expression loss in cancerAyaz Najafov, Ioannis K Zervantonakis, Adnan K Mookhtiar, et al.Pageof 11